Brompton Global Healthcare Income & Growth ETF (TSE:HIG) Price & Chart
TSE:HIG ETF Chart & Stats
- Day’s Range
- CAD 7.91 - CAD 8.02
- 52-Week Range
- CAD 6.94 - CAD 8.30
- Previous Close
- CAD 7.87
- Volume
- 8,645
- Average Volume (3M)
- 3,243
- AUM
- 71.88M
- NAV
- 7.92
- Expense Ratio
- 0.96%
- Holdings Count
- 26
- Beta
- 0.64
- Inception Date
- Apr 03, 2018
- Last Dividend Ex-Date
- Dec 31, 2026
- Dividend Yield
- (7.77%)
- Shares Outstanding
- 9,274,891
- Standard Deviation
- N/A
ETF Overview
Brompton Global Healthcare Income & Growth ETF
Brompton Global Healthcare Income & Growth ETF (TSE:HIG) is a specialized investment fund designed to provide investors with targeted exposure to the dynamic and burgeoning healthcare sector. Positioned within the sector-focused category, this ETF offers a broad-based approach to capturing growth opportunities across the global healthcare landscape. HIG strategically invests in a diverse portfolio of healthcare companies, ranging from innovative biotech firms to established pharmaceutical giants, delivering a balanced blend of income and growth potential. By focusing on the healthcare sector, this ETF taps into the relentless demand for medical advancements and healthcare services driven by an aging global population and increasing health awareness. Investors benefit not only from the intrinsic growth prospects of the sector but also from the ETF's income-generation strategy, which aims to provide regular distributions. With its comprehensive approach and sector-specific focus, Brompton Global Healthcare Income & Growth ETF is an attractive option for those seeking to capitalize on the long-term trends and innovations shaping the future of healthcare.
TSE:HIG ETF FAQ
What was TSE:HIG’s price range in the past 12 months?
What is the AUM of TSE:HIG?
Is TSE:HIG overvalued?
Does TSE:HIG pay dividends?
How many shares outstanding does TSE:HIG have?
TSE:HIG ETF Smart Score
Top 10 Holdings
| Name | Weight % |
|---|---|
| JNJJohnson & Johnson | 5.68% |
| GILDGilead Sciences | 5.60% |
| LLYEli Lilly And Company | 5.33% |
| NVSNovartis AG | 5.17% |
| CAHCardinal Health | 5.15% |
| BMYBristol-Myers Squibb Company | 4.99% |
| MRKMerck & Company | 4.96% |
| VRTXVertex Pharmaceuticals Inc. | 4.89% |
| AAgilent Technologies | 4.63% |
| MCKMcKesson Corporation | 4.42% |
| Total | 50.82% |